leisure time -WSS

leisure time

author：focus 2025-09-30 18:16:37 - browse：3

Are biotech’s dog days over? What’s a PIPE? And what can unseat Wegovy?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We dive into the the latest craze in the world of biotech finance, involving hedge funds and some insider information, and explain why not everyone thinks it’s such a good idea. We also discuss a banner month for biotech stocks and the latest twist in obesity research.

For more on what we cover, here’s more on PIPEs; here’s the news from Viking Therapeutics; here’s the latest in MASH; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： What does generative AI mean for health care? We asked experts
Next article： Why hospitals are withdrawing from US News rankings

WSS

A rare thyroid diagnosis led to unexpected, all

How to protect patients from sexual assault

Sanofi seeks simpler, safer CRISPR sickle cell cure

Advances in CAR

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Why Novartis is changing the name of its research labs

leisure time

leisure time

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Custom gene therapy hints at new path for rare disease treatments

Supreme Court strikes down use of affirmative action

WHO calls for emergency meeting on new China virus, as cases spread

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Group opposing PBM reform sets lobbying record

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Peter Hotez and the public health issue of online harassment

As digital health tech proliferates, a new institute aims to cut through hype

knowledge

Google and Epic fight stronger regulation of AI in health care

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Listen: Wegovy in the brain & pivotal Alzheimer's data

A public scorecard can help hold safety

What American doctors can learn from their Israeli counterparts

Doctors find melanoma drugs effective against rare brain cancer

hotspot

focus

hotspot

Wikipedia